Premium Industrial News

CMO Pharma-Bio Industry Capital Project Activity Continues to Soar

CMO Pharma-Bio Industry Capital Project Activity Continues to Soar

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 215 Words
Attachment: Map

SUGAR LAND--November 23, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Contract Manufacturing Organizations (CMOs) already were an important factor in the drug industry's toolbox pre-COVID, but the enormous demand generated by the pandemic catapulted their value even higher. They responded by boosting capacity and going to 24/7 shifts where possible.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?